NUFARM LIMITED — Director's Dealing 2007

Feb 15, 2007

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

	Name of entity NUFARM LIMITED
IABN 37 091 323 312

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	WILLIAM BRUCE GOODFELLOW
Date of last notice	02/02/07

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Member of Board of Trustees of the Auckland Medical Research Foundation.
Date of change	08/02/07

⁺ See chapter 19 for defined terms.

No. of securities held prior to change	Direct:
	70,787 Fully paid ord shares ٠
	Indirect:
	Pacific Custodians Pty Ltd 36,695 Fully paid ă.
	Ord Shares
	MA Goodfellow 10,787 Fully paid Ord $\blacksquare$ Shares
	St Kentigern Trust 429,855 Fully paid Ord $\blacksquare$ Shares
	Waikato Investment 113,616 Fully paid Ord ٠ Shares Company Ltd
Class	Ordinary Shares ٠
	Nufarm Step Up Securities (NSS) – Issued by ٠
	Nufarm Finance (NZ) Limited, a subsidiary of
	Nufarm Limited.
Number acquired	Indirect:
	209,700 Fully Paid ord shares π 25,462 NSS
Number disposed	Nil
Value/Consideration	Shares – Shares previously acquired by or ٠
Note: If consideration is non-cash, provide details and estimated valuation	gifted to Auckland Medical Research
	Foundation.
	NSS - Auckland Medical Research Foundation $\blacksquare$ purchased the NSS for a purchase price of
	\$2,192,287 on 26/10/06 (being A\$2,546,200)

⁺ See chapter 19 for defined terms.

No. of securities held after change	Shares
	Direct: 70,787 Fully paid ord shares $\blacksquare$
	Indirect: Pacific Custodians Pty Ltd 37,123 Fully paid ε Ord Shares
	MA Goodfellow 10,787 Fully paid Ord $\blacksquare$ Shares
	St Kentigern Trust 429,855 Fully paid Ord $\blacksquare$ Shares
	Waikato Investment 113,616 Fully paid Ord $\blacksquare$ Shares Company Ltd
	Auckland Medical Research Foundation $\blacksquare$ 209,700 Fully Paid Ord Shares
	NSS
	Indirect:
	Auckland Medical Research Foundation 25,462 $\blacksquare$ NSS
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Appointment of WB Goodfellow as Member of Trustee of the Auckland Medical Research Foundation.

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract
Nature of interest
Name of registered holder (if issued securities)
Date of change

⁺ See chapter 19 for defined terms.

No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation. to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation.
Interest after change

⁺ See chapter 19 for defined terms.